Oregon Heart & Vascular Institute offers groundbreaking procedure


​Oregon Heart & Vascular Institute (OHVI) at Sacred Heart Medical Center has been chosen as one of only three sites in Oregon to offer a new, non-surgical treatment option for patients with failing aortic valves who are too sick for traditional open-heart surgery.

Transcatheter aortic valve replacement (TAVR) allows physicians to replace a patient's diseased aortic valve without surgery and while the heart continues to beat, avoiding the need for cardiopulmonary bypass. The procedure was recently approved by the U.S. Food and Drug Administration (FDA) for commercial use in the United States after a successful multi-year clinical trial. The device has been approved for use in Europe since 2007.
The TAVR procedure will be used to treat individuals with severe aortic stenosis, also known as narrowing of the aortic valve in the heart, which decreases blood flow to the brain and the rest of the body. If left untreated, the disease can progress and eventually cause death.

“This is an important medical breakthrough for treating patients with failing heart valves, and we are excited and honored to be chosen to offer this procedure to patients our region,” said Dr. Dennis Gory, cardiologist at Oregon Heart & Vascular Institute at Sacred Heart. “More importantly, our patients can now have access this groundbreaking procedure right here at Oregon Heart & Vascular Institute, close to their homes and support system,” he said.

During the TAVR procedure, doctors create a small incision in the groin and feed the new valve, which is made of cow heart tissue and mounted on a balloon catheter, to the diseased area in the heart. Once delivered to the site, the new valve is expanded with a balloon and immediately functions in place of the patient's native valve.
Oregon Heart & Vascular Institute at Sacred Heart was among the hospitals chosen by the maker of the new valve, Edwards Lifesciences Corporation, to offer this procedure in the United States.

A team of physicians at OHVI is now trained to perform the TAVR procedure, including cardiologists Dennis Gory, M.D., and Sudeshna Banerjee, M.D. Susan Glover, R.N., is also a member of the TAVR team.
For more information about the TAVR procedure at Sacred Heart Medical Center, including video animation of the procedure and interviews with Drs. Gory and Banerjee, click here.